Which is the treatment of choice for severe aplastic anemia?

A. Explaining to the teenager that he is lucky to receive good care does not address his emotional and social needs adequately and may minimize his feelings.

B. Arranging for a video conference with his teacher and ensuring schoolwork is available is important but does not address his desire to be with friends or his emotional needs.

C. Asking the child-life specialist to help find activities to distract the teenager can be helpful for providing emotional support but may not address his concerns about being with friends and feeling frustrated.

D. Arrange a multi-disciplinary team meeting, including the teenager and his family, to discuss the situation and set goals together.

In this challenging situation, it's important to involve the patient and their family in decision-making and goal-setting. Advanced osteosarcoma with metastasis to the lungs is a serious and potentially terminal illness. The teenager's feelings and wishes should be respected and taken into consideration. A multi-disciplinary team meeting allows for open communication, including the patient, family, healthcare providers, and specialists, to discuss the situation, the patient's preferences, and the overall care plan.

A. Bone marrow transplantation.

Severe aplastic anemia is a condition characterized by a significant reduction in the number of blood cells produced by the bone marrow. The primary treatment for severe aplastic anemia is a bone marrow transplantation, also known as a stem cell transplant. This procedure involves replacing the patient's dysfunctional bone marrow with healthy bone marrow or stem cells from a suitable donor. This is done to restore normal blood cell production.

Option B (Exchange transfusion) is not the primary treatment for severe aplastic anemia but may be used in certain cases to manage complications or specific symptoms.

Option C (Liver transplantation) is not a treatment for severe aplastic anemia, as this condition primarily affects the bone marrow and blood cell production.

Option D (Administration of intravenous immunoglobulin) is not the primary treatment for severe aplastic anemia but may be used in some cases to manage complications, such as infections. However, it does not address the underlying cause of the disease, which is the failure of the bone marrow to produce enough blood cells.